LB Bohle will present three examples of pharmaceutical processing technology for oral solid dosages at INTERPHEX 2026 in New York: QbCon® 1 continuous granulation and drying system, the Laboratory coating of BFC 5 tabletsand the BTS 200 pharmaceutical sieving machine.
QbCon® Continuous Wet Granulation and Drying System 1. Image Credit: LB Bohle Maschinen und Verfahren GmbH
Visitors to the LB Bohle booth at Booth 1619 will see how the company’s latest equipment supports continuous production and improves pharmaceutical manufacturing processes and product development efficiency.
These three technology highlights will demonstrate advances in continuous oral solid dose production, laboratory tablet coating and pharmaceutical particle processing.
QbCon® 1 Truly continuous wet granulation and drying
THE QbCon® Continuous Wet Granulation and Drying System 1 represents a major advance in continuous oral solid dose production. The system combines continuous feedstock dosing, liquid twin-screw granulation and drying in one compact, mobile unit.
Advanced features include sophisticated material transfer, very short dryer residence times, automatic exhaust filter self-cleaning and high retention. Integrated control systems increase operational flexibility while enhancing operator safety.
THE QbCon® 1 designed to provide limited residence time distributions that simplify material traceability in continuous processes. This makes it easy to track materials from raw materials to finished tablets, while supporting rapid scale-up.
Integrated process analytics also help reduce resource consumption and shorten drug development times.
QbCon® Continuous Wet Granulation and Drying System 1. Image Credit: LB Bohle Maschinen und Verfahren GmbH
Laboratory coating of BFC 5 tablets
THE Laboratory coating of BFC 5 tablets will be the second major technological focus in the
Base LB Bohle.
It provides a compact, mobile, stand-alone solution for tablet coating operations, performing spraying, mixing and drying simultaneously under tightly controlled conditions to achieve optimum coating uniformity.
Airflow management, electrical systems and process control are fully integrated, with multi-frame visualization available through an intuitive touchscreen interface.
The system is suitable for batch sizes ranging from two to 13 litres. Meanwhile, the mini drum allows pilot batches as small as 170–350 ml to be processed. This does it BFC 5 it is particularly suitable for research and development as well as process optimization.
BTS 200 Pharmaceutical Sieving Machine
The third technological highlight at INTERPHEX will be the BTS 200 medicinal sievewhich demonstrates LB Bohle’s advanced engineering in particle processing.
The system can calibrate the particle size of dry or wet products and is also ideal for general mixing and screening operations, with throughput rates of up to three metric tons per hour.
A series of optimized perforated and friction cone sieve inserts allows the machine to handle a variety of powders and pharmaceutical materials.
The latest BTS 200 The design includes an innovative impeller configuration that reduces product loss, optimized CIP cleaning, electric height adjustment and user-friendly touch screen control.
Pharmaceutical sieve BTS 200. Image credit: LB Bohle Maschinen und Verfahren GmbH
Rapid Development
“Continuous manufacturing and flexible scale-up technologies are becoming increasingly important to modern oral solid dose manufacturing,” said Mike Fazio, Director of Sales and Marketing at LB Bohle LLC.
“At INTERPHEX 2026, we will demonstrate how our latest systems support faster development, improved process control and more efficient pharmaceutical production,” he added.
Visitors to booth 1619 at INTERPHEX 2026 will be able to see the systems first-hand and discuss applications in continuous manufacturing, tablet coating and pharmaceutical particle processing with LB Bohle experts.
